SynthesisSchmerz (Berlin, Germany)2026
[The influence of diagnostic labels on treatment preferences of people with musculoskeletal pain : A systematic literature review].
Synthesis in Schmerz (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients often report uncertainty about the information provided by physicians and physiotherapists, as well as difficulties in making decisions regarding medical interventions. Making autonomous and informed decisions requires clear explanations about the condition, its associated limitations, prognosis, and treatment options.
objectiveThis systematic review aimed to investigate how common diagnostic labels for the same musculoskeletal pathology influence the perceived severity of a condition and patients' treatment preferences.
methodsSystematic literature search in MEDLINE (via PubMed), the Cochrane Library, and the PEDro database.
resultsHealthy individuals as well as patients associate diagnostic labels suggesting pathoanatomical damage in musculoskeletal pain syndromes with more pain, greater disability, and a perceived need for advanced imaging and invasive interventions. Overall, there is a significant correlation between diagnostic labels and patients' treatment preferences. DISCUSSION: Diagnostic labels such as "low back pain episode," "persistent hip pain," and "bursitis," which do not suggest severe structural damage, are often associated with a better prognosis and less perceived need for invasive interventions or advanced imaging. In contrast, labels indicating structural damage (e.g., "degeneration") can trigger fear, avoidance behaviour, and catastrophizing. Using labels that promote self-efficacy and convey a positive prognosis could therefore be a valuable strategy to improve care for patients with musculoskeletal pain.
conclusionSevere-sounding diagnostic labels are associated with a preference for more invasive treatments, catastrophizing tendencies, and a perceived need for advanced imaging in individuals with musculoskeletal pain.
Indexed as
Identifiers
40045041What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.